DWP
EDIT icon

Destiny Wealth Partners’s Editas Medicine EDIT Stock Holding History

Destiny Wealth Partners’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-80
Closed -$6K – 545
2020
Q4 		$6K Buy
+80
New +$3.29K ﹤0.01% 441

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Destiny Wealth Partners's EDIT Position: Q1 2021 in Review

Destiny Wealth Partners sold out of Editas Medicine (EDIT) in Q1 2021, closing a stake of 80 shares — an estimated $6K sold.

Destiny Wealth Partners first reported a position in EDIT in Q4 2020 and held it in 1 quarter. The position peaked at $6K in Q4 2020. 312 funds tracked by Wall St. Rank hold EDIT as of Q1 2021.

  • Destiny Wealth Partners reported no remaining Editas Medicine position as of Q1 2021 after selling out during the quarter.
  • Destiny Wealth Partners sold 80 Editas Medicine shares in Q1 2021, an estimated $6K.
  • Destiny Wealth Partners first reported a position in Editas Medicine in Q4 2020 and held it in 1 quarter.
  • Destiny Wealth Partners's Editas Medicine position peaked at $6K in Q4 2020.
  • 312 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2021.

Based on Destiny Wealth Partners's 13F filing for Q1 2021, filed 22 Apr 2021.